Urogen Pharma Ltd.
URGN
Revenue
21.85M
▲3.07M▲16.33%
3 Months ChangeAssets
281.85M
▲81.28M▲40.52%
3 Months ChangeLiabilities
251.54M
▲10.83M▲4.50%
3 Months ChangeFree Cash Flow
-31.74M
▼-5.91M▼-22.86%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-09
Form 8-K
ID: 0001193125-24-234808
2024-09-24
Form 8-K
ID: 0001193125-24-224801
2024-09-13
Form 8-K
ID: 0001193125-24-218868
2024-08-15
Form 8-K
ID: 0001193125-24-200993
2024-08-13
Form 10-Q
ID: 0001437749-24-026161
2024-08-13
Form 8-K
ID: 0001193125-24-199425
2024-08-08
Form 8-K
ID: 0001193125-24-197008
2024-06-18
Form 8-K
ID: 0001193125-24-163498
2024-06-13
Form 8-K
ID: 0001193125-24-160413
2024-05-13
Form 10-Q
ID: 0001437749-24-016116